Key facts
- This page summarizes GILEAD SCIENCES, INC.'s Form 3 filing for Arcellx, Inc. (ACLX).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 28 Dec 2023, 17:09.
GILEAD SCIENCES, INC. - 28 Dec 2023 Form 3 Insider Report for Arcellx, Inc. (ACLX)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- ACLX
- Reported as of
- 28 Dec 2023
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 28 Dec 2023, 17:09:30 UTC
- Prior SEC filing
- 22 Dec 2023
- Next SEC filing
- 31 Jan 2024
- Source filing
- View source filing
- Reporting owner signature
- Gilead Sciences, Inc. By: /s/ Andrew D. Dickinson
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
GILEAD SCIENCES, INC. filed Form 3 for Arcellx, Inc. (ACLX) on 28 Dec 2023.
Change
- Previous filing in this sequence was filed on 22 Dec 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ACLX
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 6,720,803
- Date
- 28 Dec 2023
- Ownership
- Direct
* marks a reported price that did not pass the local price check.